An Open-Label, Randomized, Two-Period Crossover Definitive Bioequivalence Study With the FMI Sitagliptin/Metformin FDC Tablet and Co-Administration of the Sitagliptin and Metformin Individual Tablets After Consumption of a High-Fat Meal in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Aug 2015
At a glance
- Drugs Metformin/sitagliptin (Primary) ; Metformin; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Merck & Co
- 22 Jul 2015 According to ClinicalTrials.gov record treatment pattern and serum sample collection time points (for calculation of AUC) had been changed.
- 02 Feb 2010 Actual number of patients changed from 60 to 61 as reported by ClinicalTrials.gov.
- 08 Jul 2009 New trial record.